Literature DB >> 12566925

Molecular mechanisms for neuronal cell death by Alzheimer's amyloid precursor protein-relevant insults.

Masaoki Kawasumi1, Yuichi Hashimoto, Tomohiro Chiba, Kohsuke Kanekura, Yohichi Yamagishi, Miho Ishizaka, Hirohisa Tajima, Takako Niikura, Ikuo Nishimoto.   

Abstract

To develop a therapeutic intervention for Alzheimer's disease (AD), it is necessary to clarify the mechanisms underlying the pathogenesis of AD, in which senile plaques, neurofibrillary tangles and neuronal loss in the cerebrum are the central abnormalities. A number of studies have focused on the major component of the senile plaques, which is amyloid-beta (Abeta) and its precursor protein APP, and have investigated the roles of these molecules in the onset, progression and inhibition of AD. For multiple reasons, however, their roles in AD, especially in neuronal death, remain elusive and a unified concept for their roles has not yet been established. Recently, it has been found that APP functions normally as a neuronal surface transmembrane protein. In this article, we review the molecular mechanisms of neuronal cell death by these APP-relevant insults and discuss the functions of APP in regard to intracellular signal transducers, including c-Jun N-terminal kinase. We also revise the roles of Abeta in neuronal death and survival. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12566925     DOI: 10.1159/000067424

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  13 in total

1.  Alzheimer's therapeutics: neurotrophin domain small molecule mimetics.

Authors:  Stephen M Massa; Youmei Xie; Frank M Longo
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

2.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

Review 3.  Neuroprotective strategies in Alzheimer's disease.

Authors:  Frank M Longo; Stephen M Massa
Journal:  NeuroRx       Date:  2004-01

4.  A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury.

Authors:  Anke Di; Takeshi Kawamura; Xiao-Pei Gao; Haiyang Tang; Evgeny Berdyshev; Stephen M Vogel; You-Yang Zhao; Tiffany Sharma; Kurt Bachmaier; Jingsong Xu; Asrar B Malik
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

Review 5.  Humanin: after the discovery.

Authors:  Takako Niikura; Tomohiro Chiba; Sadakazu Aiso; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

6.  Humanin Blocks the Aggregation of Amyloid-β Induced by Acetylcholinesterase, an Effect Abolished in the Presence of IGFBP-3.

Authors:  Deanna Price; Sadaf Dorandish; Asana Williams; Brandon Iwaniec; Alexis Stephens; Keyan Marshall; Jeffrey Guthrie; Deborah Heyl; Hedeel Guy Evans
Journal:  Biochemistry       Date:  2020-05-20       Impact factor: 3.162

7.  Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer's disease.

Authors:  Jessica Ciesler; Youssef Sari
Journal:  Open J Neurosci       Date:  2013-04-08

8.  SH3-binding protein 5 mediates the neuroprotective effect of the secreted bioactive peptide humanin by inhibiting c-Jun NH2-terminal kinase.

Authors:  Yuji Takeshita; Yuichi Hashimoto; Mikiro Nawa; Hiroyuki Uchino; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

9.  Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin.

Authors:  Takako Niikura; Hirohisa Tajima; Yoshiko Kita
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 10.  Neuroprotection against neurodegenerative diseases: development of a novel hybrid neuroprotective peptide Colivelin.

Authors:  Tomohiro Chiba; Ikuo Nishimoto; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.